Chloride intracellular channel 3: A secreted pro-invasive oxidoreductase

Autor: Sara Zanivan, Jim C. Norman
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Proteomics
Proteome
Angiogenesis
Extracellular matrix
chemistry.chemical_compound
angiogenesis
stiffness
0302 clinical medicine
Cancer-Associated Fibroblasts
Neoplasms
CAF
oxidoreductase
chemistry.chemical_classification
biology
Neovascularization
Pathologic

CLIC3
invasion
Glutathione
Cell biology
Extracellular Matrix
Treatment Outcome
Disease Progression
TGM2
Female
Oxidoreductases
Oxidation-Reduction
Protein Binding
integrin
Integrin
Mice
Nude

Editorials: Cell Cycle Features
Models
Biological

Article
03 medical and health sciences
Oxidoreductase
Chloride Channels
GTP-Binding Proteins
Cell Line
Tumor

Human Umbilical Vein Endothelial Cells
cancer
Animals
Humans
Neoplasm Invasiveness
Protein Glutamine gamma Glutamyltransferase 2
Molecular Biology
Transglutaminases
Biological Transport
Cell Biology
Molecular biology
Survival Analysis
Mice
Inbred C57BL

Chloride intracellular channel 3
secretome
030104 developmental biology
chemistry
Cell culture
biology.protein
030217 neurology & neurosurgery
Developmental Biology
Zdroj: Cell Cycle
Nature Communications
ISSN: 1551-4005
1538-4101
Popis: The secretome of cancer and stromal cells generates a microenvironment that contributes to tumour cell invasion and angiogenesis. Here we compare the secretome of human mammary normal and cancer-associated fibroblasts (CAFs). We discover that the chloride intracellular channel protein 3 (CLIC3) is an abundant component of the CAF secretome. Secreted CLIC3 promotes invasive behaviour of endothelial cells to drive angiogenesis and increases invasiveness of cancer cells both in vivo and in 3D cell culture models, and this requires active transglutaminase-2 (TGM2). CLIC3 acts as a glutathione-dependent oxidoreductase that reduces TGM2 and regulates TGM2 binding to its cofactors. Finally, CLIC3 is also secreted by cancer cells, is abundant in the stromal and tumour compartments of aggressive ovarian cancers and its levels correlate with poor clinical outcome. This work reveals a previously undescribed invasive mechanism whereby the secretion of a glutathione-dependent oxidoreductase drives angiogenesis and cancer progression by promoting TGM2-dependent invasion.
The secretome from cancer and stromal cells contributes to the creation of a microenvironment, which in turn contributes to invasion and angiogenesis. Here, the authors compare the secretomes of immortalized normal fibroblasts and cancer-derived fibroblast and identify CLIC3 as a driver of cancer progression.
Databáze: OpenAIRE